Cybin Corp. and IntelGenx Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin FilmMPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp. and FinancingMydecine Innovations Group Adds World Renowned, 7-Time Nobel Peace Prize Nominee Dr. M.S Reddy to its Scientific AdvisorMydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory BoardField Trip Psychedelics Inc. Launches Field Trip Basecamp, a therapeutic program designed for combat veterans, first resCannaGlobal, Sansero Life Sciences and Rise Wellness Merge to Create a New International Psychedelics CompanySilo Wellness Is Headed Up By A Management Team That Has Been Ahead of The CurveRevive Therapeutics Announces Submission of Investigational New Drug Application (IND) with U.S. FDA for Phase 3 ConfirmCybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead ConcurHAVN Life Sciences Continues To Execute On Growth Initiatives Ahead Of Its Upcoming Public ListingMindMed Developing IP For Personalized Psychedelic Assisted TherapiesNuminus announces Clinical Advisory Council to advance integrated wellness modelRritual Announces Dr. Mike Hart as PresidentThe Multi-Billion Dollar Functional Mushroom Market Is Up For GrabsMydecine Innovations Group Bolsters Scientific Advisory Board Adding a Leading Neuroscientist and a Psychopharmacology SField Trip Is Shifting Gears To Expedite IPO ProcessMydecine Innovations Group Signs Definitive Agreement to Acquire Mindleap Health’s Advanced Digital Telehealth PlatforNew Wave Holdings Corp Appoints Dr. Carolyn Myers As VP Of Commerical DevelopmentNew Wave Holdings Corp Appoints Dr. Dennis McKenna to Psychedelic Research Advisory BoardChampignon Provides Corporate Update; Announces Name Change, Rebranding and Planned Spin Out

Technical420 Site Search

Returned 7 result(s).

Cybin Corp. and IntelGenx Corp. Enter Into Feasibility Agreement for Fast-Acting, Orally-Dissolving Psilocybin Film

Cybin Corp., Canada's premier mushroom life sciences company focused on advancing psychedelic and nutraceutical-based products derived from fungi, is pleased to announce that it has entered into a feasibility agreement with IntelGenx Corp. (OTCQB:IGXT; TSX-V:IGX) for the development of an orally-dissolving film for the delivery of pharmaceutical-grade psilocybin, subject to…

Cybin Corp. Announces Reverse Take-Over Transaction and the Engagement of Stifel GMP and Eight Capital to Co-Lead Concurent Private Placement of up to $21M

Cybin Corp., a mushroom life sciences company focused on psychedelic medicines and nutraceutical products, is pleased to announce that it has entered into an amalgamation agreement dated June 26, 2020 with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly-owned subsidiary of Clarmin. Completion of the transactions contemplated…

The Multi-Billion Dollar Functional Mushroom Market Is Up For Grabs

One of the most exciting trends of 2020 has been the emergence of the functional mushroom market. This vertical has been generating substantial traction over the last decade and this is a trend that is only getting more significant. According to a report by Research and Markets, the global edible…

Cybin Corp: A Mushroom Life Sciences Leader In The Making

Last month, we issued an update on Cybin Corp after having the opportunity to speak with members of the management team. Following our conversation, we felt much more comfortable with the business and want to provide a more in-depth look at the opportunity. Cybin is a life sciences company that…

Functional Mushroom Products Are Providing Psychedelics Companies With A Quick Path To Revenue

When people first hear about the mushroom market, a majority of people do not take it seriously and write it off as a new fad. Unfortunately, these people could not be more wrong. The mushroom industry encompasses a number of high-growth verticals and this is a trend that is not…

7 Companies Focused On Psychedelic Therapies For Treating Mental Illness

2020 has been a challenging year for the global economy as the world tries to recover from the COVID-19 outbreak. Following the outbreak, we have noticed a bifurcation in the markets where some sectors would considerably outperform others. For example, companies like Clorox and Amazon have reported impressive growth during…

5 Companies Leading The New Wave Of Therapeutics In The Psychedelic Sector

One of the most exciting trends in the market is related to the work that is being undertaken on the biotech side of the psychedelic industry. A few years ago, if I was told that the psychedelic market will be one of the next big opportunities, I most likely would…

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link